Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 billion, as the ...

A genetic signature including four genes in gastric cancer is linked to an increase in recurrence and mortality.

Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...

SpringWorks Therapeutics (SWTX) stock rose early Monday after the biopharmaceutical company agreed to be acquired by German science and technology firm Merck, which aims to strengthen its healthcare ...